Prognostic Significance of Late Gadolinium Enhancement in Fabry Disease-A Systematic Review and Meta-Analysis.
暂无分享,去创建一个
G. Renda | S. Gallina | M. di Mauro | M. Khanji | F. Ricci | D. Mansour | G. Bisaccia | Lorenzo V. Molinari
[1] R. Manka,et al. Clinical and CMR characteristics associated with cardiac events in patients with Fabry disease. , 2023, International journal of cardiology.
[2] James A. White,et al. Integrating Cardiac MRI Imaging and Multidisciplinary Clinical Care is associated with Improved Outcomes in Patients with Fabry Disease.: Improving clinical outcomes in patients with Fabry Disease. , 2022, Current problems in cardiology.
[3] D. G. Clark,et al. Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry Disease. , 2022, Journal of the American College of Cardiology.
[4] E. Arbustini,et al. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week. , 2021, Journal of the American College of Cardiology.
[5] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.
[6] M. Beer,et al. Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease. , 2014, The American journal of cardiology.
[7] C. Morel,et al. Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease. , 2019, Radiology.